Log in Book a Demo

US Pharma & Biotech Research and Development - PPC Market Share Analysis July 2026

Leveraging Adthena’s Whole Market View, this analysis explores recent trends in Google Ads for the US Research and Development category from the last month. Our Data Analyst, Ask Arlo provides commentary on key findings.

Research and Development – US

Google AI Overview visibility for Pharma & Biotech Research and Development US

See how often AIOs appear and how search intent is distributed across buying signals.

See more data

AIO Frequency

How often a Google AI overview appears on search terms relevant to this category.

Frequency Percentage
Frequency 75.7063686745
24.2936313255
75%

Complex Query Frequency

A complex query is a longer, more detailed search that often contains multiple keywords, specific conditions, or multi-part questions.

Frequency Percentage
Frequency 13
87
13%

Search Intent Distribution

Breakdown of search queries by their underlying goal.

Intent Distribution
Investigational 4%
Transactional 2%
Navigational 3%
Seasonal 0%
Local 0%
Problem Solving 12%

Copyright © Adthena. All rights reserved.

Market Exposure

Share of Clicks for top 10 US Pharma & Biotech Research and Development brands

Here are the Top 10 competitors in the industry by Share of Clicks for the last month.

See more data
Share of Clicks - Last month
Share of Clicks - Last month
Domain Share of clicks
lilly.com 38.45
regeneron.com 5.16
gsk.com 5.09
ro.co 4.86
pfizerforall.com 3.65
abbvie.com 3.64
merck.com 3.08
sequencing.com 2.35
evenity.com 1.8
ziphealth.co 1.5
others 30.42
  • lilly.com - 38.45%
  • regeneron.com - 5.16%
  • gsk.com - 5.09%
  • ro.co - 4.86%
  • pfizerforall.com - 3.65%
  • abbvie.com - 3.64%
  • merck.com - 3.08%
  • sequencing.com - 2.35%
  • evenity.com - 1.8%
  • ziphealth.co - 1.5%
  • others - 30.42%

Copyright © Adthena. All rights reserved.

In the PPC landscape, lilly.com dominates with 38.45% click share, while ‘others’ collectively hold 30.42%, showcasing diverse competition.

Market Exposure

Share of Spend for the top 10 US Pharma & Biotech Research and Development brands

Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month. 

See more data
Share of Spend - Last Month
Share of Spend - Last Month
Date lilly.com pfizerforall.com ro.co evenity.com ziphealth.co hims.com goodrx.com scemblix.com abbvie.com novonordisk-us.com
2026/07/01 30.84% 8.18% 5.84% 5.26% 0.13% 0.38% 3.05% 2.05% 0.51% 0.43%
2026/07/02 25.38% 8.07% 8.54% 3.17% 0.18% 0.97% 2.67% 1.96% 1.51% 1.59%
2026/07/03 29.3% 8.08% 6.93% 1.39% 0% 0.49% 2.64% 1.93% 1.6% 2.36%
2026/07/04 28.92% 7.82% 4.25% 5.37% 0% 0.58% 3.22% 1.99% 4.07% 2.3%
2026/07/05 33.43% 7.29% 6.69% 3.17% 0% 0.69% 1.74% 1.36% 2.99% 0.34%
2026/07/06 30.68% 8.07% 7.6% 3.7% 0.13% 0.64% 2.23% 1.9% 0.62% 1.91%
2026/07/07 34.12% 7.66% 5.69% 3.78% 0.12% 1.81% 0.77% 1.59% 1.28% 2.86%
2026/07/08 30.58% 7.78% 8.04% 5% 0.77% 2% 2.85% 1.63% 0.34% 3.05%
2026/07/09 33.6% 5.62% 10.83% 4.47% 2.88% 2.04% 1.44% 1.88% 0.68% 1.13%
2026/07/10 34.88% 5.47% 10% 1.28% 4.14% 1.64% 1.06% 1.58% 1.02% 2.17%
2026/07/11 31.58% 5.76% 9.3% 2.72% 5.06% 1.64% 1.82% 1.86% 2.2% 1.94%
2026/07/12 35.19% 5.89% 9.92% 2.63% 3.27% 0.85% 1.1% 1.57% 1.96% 2.38%
2026/07/13 35.89% 6.77% 8.58% 1.23% 3.06% 0.82% 2.29% 1.48% 1.01% 1.61%
2026/07/14 37% 6.37% 8.51% 5.04% 1.24% 0.81% 1.2% 0.98% 0.82% 1.6%
2026/07/15 37.49% 6.31% 6.39% 4.6% 0.21% 0.55% 1.51% 2.55% 1.88% 1.52%
2026/07/16 40.09% 5.92% 6.68% 2.74% 0.93% 0.96% 0.86% 2.23% 0.99% 2.3%
2026/07/17 35.22% 7.56% 8.31% 1.84% 2.09% 1.9% 1.38% 1.53% 1.4% 1.96%
2026/07/18 39.67% 7.14% 6.86% 3.81% 2.71% 1.52% 0.01% 2.03% 1.99% 2.03%
2026/07/19 34.45% 6.63% 8.71% 2.87% 4.65% 1.74% 1.16% 1.67% 3.05% 1.57%
2026/07/20 39.36% 6.95% 6.29% 4.04% 2.24% 2.7% 3.56% 2.26% 1.58% 1.84%
2026/07/21 36.92% 6.38% 8.49% 5.03% 1.24% 0.81% 1.2% 0.98% 0.82% 1.6%
2026/07/22 28.65% 4.61% 10.57% 2.07% 3.38% 2.44% 1.16% 1.88% 2.2% 1.26%
2026/07/23 34.38% 3.92% 9.04% 2.27% 2.29% 1.7% 0.77% 1.49% 0.85% 3.11%
2026/07/24 39.14% 5.06% 7.47% 2.55% 1.99% 3.34% 2.23% 2.07% 0.67% 1.15%
2026/07/25 37.63% 3.42% 9.53% 2.32% 2.73% 1.93% 1.31% 2.05% 1.04% 1.95%
2026/07/26 37.86% 5.35% 7.55% 2.27% 2.66% 1.34% 1.68% 1.76% 2.36% 0.9%
2026/07/27 35.32% 5.78% 6.47% 2.4% 2.43% 2.14% 1.17% 1.13% 0.8% 1.67%
2026/07/28 37.96% 4.52% 7.65% 3.58% 1.18% 1.66% 1.76% 1.57% 0.84% 0.36%
2026/07/29 39.55% 5.76% 8.23% 3.67% 0.73% 0.7% 2.14% 1.36% 1.44% 1.56%
2026/07/30 36.95% 4.34% 9.09% 3.47% 2.46% 2.35% 1.53% 1.14% 0.34% 1.16%
2026/07/31 43.24% 5.54% 5.4% 3.32% 2.81% 1.34% 1.3% 1.15% 0.85% 0.65%
  • lilly.com
  • pfizerforall.com
  • ro.co
  • evenity.com
  • ziphealth.co
  • hims.com
  • goodrx.com
  • scemblix.com
  • abbvie.com
  • novonordisk-us.com

Copyright © Adthena. All rights reserved.

Lilly.com dominated July, peaking at 43.24% on the 31st. Pfizerforall.com saw a decline, ending at 5.54%. Ro.co fluctuated, closing at 5.4%. Evenity.com remained low, finishing at 3.32%.

Market Exposure

Competitor Count for US Pharma & Biotech Research and Development

Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month. 

See more data
Competitor Count - Last month
Competitor Count - Last month
Date Competitor Count
2026/07/01 448
2026/07/02 454
2026/07/03 469
2026/07/04 457
2026/07/05 460
2026/07/06 467
2026/07/07 468
2026/07/08 464
2026/07/09 448
2026/07/10 468
2026/07/11 448
2026/07/12 455
2026/07/13 470
2026/07/14 459
2026/07/15 446
2026/07/16 446
2026/07/17 446
2026/07/18 421
2026/07/19 431
2026/07/20 417
2026/07/21 459
2026/07/22 491
2026/07/23 497
2026/07/24 496
2026/07/25 493
2026/07/26 492
2026/07/27 474
2026/07/28 481
2026/07/29 465
2026/07/30 467
2026/07/31 449

Copyright © Adthena. All rights reserved.

July began with 448 advertisers, peaking mid-month at 497. A slight decline followed, ending at 449.

Campaign Efficiency

Market Loss & Market Gains for US Pharma & Biotech Research and Development

Here we’re looking at the Top 10 biggest industry movers by market share gains and losses for the last 30 days.

See more data
Market Loss & Market Gains - Last month
Market Loss & Market Gains - Last month
Name Market Trend
lilly.com 3.82%
regeneron.com 0.8%
ziphealth.co 0.46%
rugiet.com 0.45%
hims.com 0.44%
freestyle.abbott -0.41%
abbvie.com -0.62%
merck.com -0.72%
pfizerforall.com -0.98%
gsk.com -1.46%

Copyright © Adthena. All rights reserved.

Lilly.com surged with a 3.82% click share increase, while gsk.com faced a 1.46% decline. Regeneron.com rose by 0.8%, contrasting with pfizerforall.com’s 0.98% drop.

Campaign Efficiency

US Pharma & Biotech Research and Development Share of Impressions

Take a look at the Top 10 competitors in the industry by Share of Impressions over the last month.

See more data
Date lilly.com ro.co pfizerforall.com ziphealth.co regeneron.com abbvie.com gsk.com merck.com freestyle.abbott novonordisk-us.com
2026/07/01 20.34% 7.89% 7% 0.19% 2.74% 0.57% 2.4% 3.86% 1.56% 0.45%
2026/07/02 16.39% 10.08% 6.61% 0.19% 1.92% 1.98% 2.1% 3.74% 1.57% 1.67%
2026/07/03 17.83% 8.39% 6.46% 0% 3.15% 1.6% 2.1% 3.76% 2.35% 2.51%
2026/07/04 18.13% 5.4% 6.2% 0% 4.04% 5.58% 1.99% 3.05% 2.37% 2.37%
2026/07/05 21.3% 8.1% 5.7% 0% 2.33% 4.03% 1.91% 2.34% 4.6% 0.38%
2026/07/06 19.7% 10.05% 6.73% 0.17% 1.17% 0.6% 2.1% 2.83% 3.01% 2.09%
2026/07/07 22.15% 7.47% 6.7% 0.16% 2.6% 1.82% 1.97% 2.52% 3.03% 3.13%
2026/07/08 20.93% 12.17% 6.48% 0.85% 1.27% 0.55% 1.94% 1.42% 1.5% 3.35%
2026/07/09 22.5% 14.8% 4.49% 3.33% 2.53% 1% 1.71% 2.57% 1.72% 1.27%
2026/07/10 21.5% 13.24% 4.22% 4.73% 0.92% 1.54% 1.86% 2.2% 2.71% 2.62%
2026/07/11 20.3% 12.32% 4.21% 6.22% 2.36% 3.36% 1.91% 2.63% 1.89% 1.9%
2026/07/12 22.47% 13.48% 4.35% 4.33% 1.03% 3.19% 1.94% 2.79% 1.34% 2.57%
2026/07/13 22.57% 10.91% 5.06% 3.96% 0.91% 1.6% 1.97% 2.57% 4.05% 1.81%
2026/07/14 24.53% 12.15% 5.17% 1.53% 1.63% 1.14% 2.5% 1.84% 0.65% 1.86%
2026/07/15 26.15% 8.4% 4.98% 0.26% 2.31% 3.01% 2.57% 3.17% 1.14% 1.92%
2026/07/16 27.02% 9.12% 4.77% 1.11% 1.65% 1.38% 2.17% 2.2% 4.82% 2.7%
2026/07/17 24.25% 11.2% 5.53% 2.79% 1.91% 2.11% 2.28% 0.93% 0.66% 2.5%
2026/07/18 28.28% 10.07% 5.85% 3.87% 0.4% 3.57% 1.83% 1.22% 1.11% 2.48%
2026/07/19 23.54% 11.67% 5.23% 6.01% 2.82% 4.16% 1.93% 1.97% 1.01% 1.78%
2026/07/20 27.84% 8.5% 5.9% 3.25% 2.88% 2.58% 1.71% 1.5% 1.29% 2.26%
2026/07/21 24.53% 12.15% 5.17% 1.53% 1.63% 1.14% 2.5% 1.84% 0.65% 1.86%
2026/07/22 17.71% 12.85% 3.42% 3.91% 1.97% 3.34% 1.87% 1.56% 2.37% 1.31%
2026/07/23 21.07% 11.8% 2.99% 2.89% 2.95% 1.06% 1.35% 1.71% 2.55% 3.46%
2026/07/24 26.25% 9.9% 4.19% 2.7% 1.75% 1.04% 1.56% 1.67% 0.93% 1.39%
2026/07/25 24.41% 13.39% 2.95% 3.51% 2.54% 1.88% 1.88% 2.84% 0.62% 2.23%
2026/07/26 26.18% 10.45% 4.21% 3.22% 2.31% 3.05% 1.56% 0.94% 1.29% 0.97%
2026/07/27 23.48% 8.2% 4.48% 3.03% 3.48% 1.22% 1.69% 1.62% 1.28% 1.81%
2026/07/28 24.94% 10.54% 3.72% 1.58% 2.58% 1.26% 1.17% 2.62% 1.97% 0.41%
2026/07/29 26.31% 11.27% 4.5% 0.88% 1.58% 2.83% 0.95% 2.52% 2.12% 1.8%
2026/07/30 23.83% 13.23% 3.27% 3.26% 3.15% 0.5% 1.11% 3.19% 2.62% 1.39%
2026/07/31 29.2% 7.67% 5.01% 3.89% 2.09% 1.45% 1.36% 1.34% 1.07% 0.81%
  • lilly.com
  • ro.co
  • pfizerforall.com
  • ziphealth.co
  • regeneron.com
  • abbvie.com
  • gsk.com
  • merck.com
  • freestyle.abbott
  • novonordisk-us.com

Copyright © Adthena. All rights reserved.

Lilly.com led July with a steady rise, peaking at 29.20% on the 31st. Ro.co fluctuated, ending at 7.67%. Pfizerforall.com saw a dip, closing at 5.01%. Ziphealth.co surged mid-month, finishing at 3.89%.

Campaign Efficiency

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Research and Development

Ever wondered how your rivals’ ads are doing? Here we can see the top-performing ads in the industry over the last month.

See more data
Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Research and Development - Last month
  1. 1
    FreeStyle Libre 3 Plus Sensor - Guided Support and Resources https://www.freestyle.abbott

    The FreeStyle Libre 3 Plus Sensor gives you accurate glucose readings anytime.

  2. 2
    Get Wegovy Online - Unlimited Care For $39/mo https://www.goodrx.com/

    FDA approved Wegovy prescriptions starting as low as $149/mo plus $39/mo subscription.

  3. 3
    Lilly - A Medicine Company - Learn About A Medicine Company https://www.lilly.com

    We're in The Business of Health. Lilly - A Medicine Company. Lilly Medicines Have Helped People...

  4. 4
    PfizerForAll™ - Welcome To Patient Resources https://www.pfizerforall.com/

    Welcome to PfizerForAll. Answers and Care, All In One Place. Pfizer Has Your Back with Answers and Care, All in One Place at PfizerForAll.

  5. 5
    Eli Lilly's Zepbound - Lowest Price, Guaranteed https://www.ro.co/zepbound/vials

    Ongoing reqd membership & med cost vary. See Rx warning.

Copyright © Adthena. All rights reserved.

In the competitive landscape of pharmaceuticals, Abbott’s FreeStyle Libre 3 Plus Sensor ad emphasizes precision in glucose monitoring. GoodRx offers affordability with Wegovy prescriptions, while Lilly highlights its health commitment. PfizerForAll provides comprehensive patient resources, and Ro.co guarantees the lowest price for Eli Lilly’s Zepbound.

Frequently Asked Questions

Customer Success Stories

the7stars achieves Google Ads PPC campaign optimization​ with Adthena

Leveraging Adthena's comprehensive insights, the7stars and their lottery client optimized their PPC campaigns and organic strategies, resulting in substantial cost savings and improved campaign performance. Read case study

Sage case study: 75% decrease in CPCs with Adthena

Sage, a leading UK software provider, used Adthena’s brand protection strategy to curb rising CPC costs. By identifying brand infringements and optimizing spend, they effectively strengthened their brand protection strategy and increased ROI.Read case study

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Vodafone used Adthena data to optimize results from the launch of the Samsung S22 product. Combining Adthena’s Strategic Insights with Google Smart Bidding, Vodafone was able to maintain a flexible strategy that leveraged both manual and automated bidding. Leveraging Adthena’s Search Term Opportunities report also allowed Vodafone to implement 27 keyword terms across their business line, driving an increase in revenue at a positive ROAS.Read case study

Get the full picture

See this data specific to your brand performance

The data on this page is just a sample of the billions of data points we hold at Adthena. The insights generated by Ask Arlo, leverage real-time GenAI to answer questions about your search data.

Our search consultants can introduce you to Whole Market View data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the locations that you need monitoring.

Related reports

UK
Pharma & Biotech

UK Research and Development

AUS